Status:
COMPLETED
Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in Cardiac Resynchronisation Therapy (CRT) Patients
Lead Sponsor:
Abbott Medical Devices
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
It's the aim of this study to analyse efficacy and reliability of VectSelect Feature for avoidance of phrenic nerve stimulation in cardiac resynchronisation therapy (CRT) patients.
Eligibility Criteria
Inclusion
- indication for CRT-D implantation / upgrade
- written informed consent
Exclusion
- pregnancy
- age \< 18 years
- patients, who cannot visit the routine follow ups (within first 3.5months)
- participants to other studies with active treatment arm
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01244308
Start Date
March 1 2008
End Date
August 1 2011
Last Update
February 4 2019
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Einrichtungen der RWTH Aachen
Aachen, Germany, 52074
2
Hufeland Klinikum GmbH
Bad Langensalza, Germany, 99947
3
Cardioangiologisches Centrum Bethanien
Frankfurt am Main, Germany, 60389
4
Universitätsklinikum Gießen und Marburg GmbH Sitz Gießen
Giessen, Germany, 35392